BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5118473)

  • 1. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
    [No Abstract]   [Full Text] [Related]  

  • 2. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 3. The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.
    Reisner EG; Amos DB
    Transplantation; 1972 Oct; 14(4):455-61. PubMed ID: 4404957
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic change and cell maturation in murine thymocytes.
    Lance EM; Cooper S; Boyse EA
    Cell Immunol; 1970 Nov; 1(5):536-44. PubMed ID: 4943362
    [No Abstract]   [Full Text] [Related]  

  • 5. The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect.
    Cohen IR; Feldman M
    Cell Immunol; 1970 Nov; 1(5):521-35. PubMed ID: 4108697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression of the C3H theta antigen in bone marrow lymphocytes of CBA T6-T6 mice treated with various hydrolases].
    Halpern B; Bona C; Heuclin C; Robineaux R; Crepin Y
    C R Acad Hebd Seances Acad Sci D; 1972 Jun; 274(23):3139-44. PubMed ID: 4626874
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural human antibodies to "hidden" membrane components.
    Rosenberg SA; Rogentine GN
    Nat New Biol; 1972 Oct; 239(94):203-4. PubMed ID: 4507729
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of neuraminidase on serological properties of murine lymphoid cells.
    Schlesinger M; Amos BD
    Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible inhibition of lymphocyte-mediated cytotoxicity by cytochalasin B.
    Cerottini JC; Brunner KT
    Nat New Biol; 1972 Jun; 237(78):272-3. PubMed ID: 4504462
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of the neuraminidase-revealed antigens of human lymphocytes and erythrocytes.
    Reisner EG
    Transplantation; 1975 Apr; 19(4):357-60. PubMed ID: 1171544
    [No Abstract]   [Full Text] [Related]  

  • 12. The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.
    Ray PK; Gewurz H; Simmons RL
    Clin Exp Immunol; 1972 Jul; 11(3):441-60. PubMed ID: 5042921
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterologous antiserum to thymus-derived cells in the guinea-pig.
    Shevach E; Green I; Ellman L; Maillard J
    Nat New Biol; 1972 Jan; 235(53):19-21. PubMed ID: 4553462
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytolysis of neuraminidase-treated autochthonous lymphoid cells by autologous serum.
    Ray PK; Sundaram K
    Clin Exp Immunol; 1975 Mar; 19(3):529-32. PubMed ID: 1204249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine autoantibodies to a cryptic membrane antigen; possible explanation for neuraminidase-induced increase in cell immunogenicity.
    Rosenberg SA; Schwarz S
    J Natl Cancer Inst; 1974 Apr; 52(4):1151-5. PubMed ID: 4826586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cellular mechanisms of immunologic facilitation. Study of 2 models in vitro].
    Fontaine J; Oppenheim SE; Voisin GA
    C R Acad Hebd Seances Acad Sci D; 1972 Apr; 274(16):2404-7. PubMed ID: 4624978
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells.
    Niederhuber JE; Möller E
    Cell Immunol; 1972 Apr; 3(4):559-68. PubMed ID: 4554087
    [No Abstract]   [Full Text] [Related]  

  • 19. Target cell lysis mediated by soluble cytotoxin released from stimulated lymphocytes.
    Peter JB; Dawkins RL
    Nat New Biol; 1971 Jul; 232(29):79-80. PubMed ID: 5285342
    [No Abstract]   [Full Text] [Related]  

  • 20. Human lymphocyte antigen reactivity modified by neuraminidase.
    Grothaus EA; Flye MW; Yunis E; Amos DB
    Science; 1971 Aug; 173(3996):542-4. PubMed ID: 5564043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.